JSPJX
Price
$22.29
Change
-$0.17 (-0.76%)
Updated
Sep 5 closing price
Net Assets
178.47M
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

JSPJX vs RGEBX

Header iconJSPJX vs RGEBX Comparison
Open Charts JSPJX vs RGEBXBanner chart's image
Jackson Square Large-Cap Growth I
Price$22.29
Change-$0.17 (-0.76%)
VolumeN/A
Net Assets178.47M
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
JSPJX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JSPJX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSPJX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. JSPJX (178M). JSPJX (0.00) and RGEBX (0.00) have matching dividends . JSPJX was incepted earlier than RGEBX: JSPJX (32 years) vs RGEBX (11 years). JSPJX (1.11) and RGEBX (1.09) have similar cost to investors . RGEBX is a more actively managed with annual turnover of: 25.00 vs. JSPJX (13.00). RGEBX has a lower initial minimum investment than JSPJX: RGEBX (250) vs JSPJX (2500). JSPJX annual gain was more profitable for investors over the last year : 20.49 vs. RGEBX (17.59). RGEBX return over 5 years is better than : 38.71 vs. JSPJX (-12.73).
JSPJXRGEBXJSPJX / RGEBX
Total Expense Ratio0.991.0991%
Annual Report Gross Expense Ratio1.111.09102%
Fund Existence32 years11 years-
Gain YTD16.27515.398106%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets178M332B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year20.4917.59116%
Returns for 3 years92.9957.61161%
Returns for 5 years-12.7338.71-33%
Returns for 10 years-14.4791.44-16%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
FRPH25.47-0.03
-0.12%
FRP Holdings
CNA48.01-0.94
-1.92%
CNA Financial Corp
PMAX0.26-0.03
-9.59%
Powell Max Ltd